Nov 7, 2024 08:30AM
Oct 17, 2024 07:30AM
Aug 6, 2024 04:01PM
Jul 24, 2024 06:33AM
Jul 24, 2024 06:30AM
May 10, 2023 07:00AM
Mar 29, 2023 07:04AM Pieris Pharma (PIRS) Reports FY22 Results, Provides Business Update
Mar 29, 2023 07:00AM
May 25, 2022 03:00PM
Feb 23, 2022 08:00AM
Jan 14, 2022 08:00AM
Jan 3, 2022 07:05AM
Jan 3, 2022 07:00AM
Nov 11, 2021 08:05AM Pieris Pharmaceuticals To Participate In Upcoming Investor Conferences
Nov 8, 2021 08:00AM
Nov 2, 2021 07:00AM
Oct 26, 2021 08:00AM
Oct 19, 2021 07:00AM
Oct 6, 2021 08:03AM
Oct 6, 2021 08:00AM
Sep 9, 2021 08:00AM Pieris Pharmaceuticals to Participate in Upcoming Investor Conferences
Aug 24, 2021 09:00AM
Aug 4, 2021 07:00AM
Aug 3, 2021 08:00AM
Jul 28, 2021 08:00AM
Jun 25, 2021 07:03AM
Jun 25, 2021 07:00AM
Jun 24, 2021 09:26AM Pre-Open Stock Movers 06/24: (MRIN) (RCUS) (LLY) Higher; (PRTG) (RAD) (BIIB) Lower (more...)
Jun 24, 2021 08:01AM
Jun 24, 2021 08:00AM
May 26, 2021 09:23AM
May 25, 2021 09:28AM
May 25, 2021 08:08AM
May 25, 2021 08:00AM
May 20, 2021 08:00AM Pieris Pharmaceuticals to Present at the Jefferies 2021 Virtual Healthcare Conference
May 17, 2021 07:00AM
Mar 30, 2021 07:00AM
Mar 25, 2021 08:00AM
Mar 23, 2021 08:00AM
Feb 23, 2021 08:00AM
Jan 19, 2021 08:05AM
Jan 19, 2021 08:00AM FDA Lifts Partial Clinical Hold on PRS-343 Phase 1 Studies
Nov 10, 2020 08:00AM
Nov 4, 2020 07:00AM
Oct 28, 2020 08:00AM
Sep 20, 2020 11:00AM
Sep 3, 2020 04:30PM
Aug 10, 2020 07:00AM
Aug 10, 2020 06:35AM Pieris Pharma (PIRS), Lilly (LLY) Enter Pact to Evaluate Combination of PRS-343 With Ramucirumab and Paclitaxel in Gastric Cancer
Aug 10, 2020 06:30AM

322,086 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All